Skip to main content
Top
Published in: Tumor Biology 5/2013

01-10-2013 | Research Article

Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population

Authors: Xin Tian, Ye Tian, Ping Ma, Chengguang Sui, Fandong Meng, Yan Li, Liye Fu, Tao Jiang, Yang Wang, Youhong Jiang

Published in: Tumor Biology | Issue 5/2013

Login to get access

Abstract

X-ray repair cross-complementing group 3 (XRCC3) plays a vital role in maintaining the stability of genome by homologous recombination repair for DNA double-strand breaks. The genetic polymorphism of XRCC3 C241T has been implicated in lung cancer risk, but the findings across published studies in Asians are inconsistent and inconclusive. To estimate the precise association of XRCC3 C241T polymorphism with lung cancer risk, a meta-analysis of all currently available studies in Asians was performed. A comprehensive search of the PubMed, Embase, Web of Science, and China National Knowledge Infrastructure databases was conducted for eligible studies based on the inclusion criteria. The pooled odds ratios (ORs) with corresponding 95 % confidence intervals (CIs) were calculated to assess the association. Besides, subgroup analysis and sensitivity analysis were also performed for further estimation. Seven available studies with a total of 7,398 subjects were finally included into this meta-analysis. The overall ORs indicated that the XRCC3 C241T polymorphism was not associated with a lung cancer risk among Asians in all genetic contrast modes (ORT allele vs. C allele = 1.08, 95 % CI 0.95–1.24, P OR = 0.252; ORTT vs. CC = 1.30, 95 % CI 0.69–2.45, P OR = 0.426; ORCT vs. CC = 1.07, 95 % CI 0.93–1.24, P OR = 0.363; ORTT + CT vs. CC = 1.08, 95 % CI 0.94–1.24, P OR = 0.300; ORTT vs. CC + CT = 1.29, 95 % CI 0.68–2.43, P OR = 0.439). We failed to identify significant association between the XRCC3 C241T polymorphism and risk of lung cancer in Chinese and population-based studies. Interestingly, the pooled ORs in hospital-based studies indicated that the XRCC3 C241T variant carriers were more susceptible to lung cancer (ORT allele vs. C allele = 1.27, 95 % CI 1.04–1.56, P OR = 0.019; ORCT vs. CC = 1.26, 95 % CI 1.01–1.57, P OR = 0.045; ORTT + CT vs. CC = 1.28, 95 % CI 1.03–1.59, P OR = 0.027). Sensitivity analysis confirmed the stability and liability of all results. This meta-analysis suggests that the XRCC3 C241T polymorphism may not exert a risk effect on the lung cancer risk in Asians, although a statistically significant association was observed among the hospital-based studies. Thus, the precise relationship between the XRCC3 C241T variant and lung cancer risk needs further confirmation in future studies with large available data.
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
4.
go back to reference Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol. 2012;7:954–62.CrossRefPubMed Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y. Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population. J Thorac Oncol. 2012;7:954–62.CrossRefPubMed
5.
go back to reference Steliga MA, Dresler CM. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol Clin N Am. 2011;20:605–18.CrossRefPubMed Steliga MA, Dresler CM. Epidemiology of lung cancer: smoking, secondhand smoke, and genetics. Surg Oncol Clin N Am. 2011;20:605–18.CrossRefPubMed
6.
go back to reference Liu H, Li HY, Chen HJ, Huang YJ, Zhang S, Wang J. EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis. Tumour Biol. 2013;34:155–63.CrossRefPubMed Liu H, Li HY, Chen HJ, Huang YJ, Zhang S, Wang J. EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis. Tumour Biol. 2013;34:155–63.CrossRefPubMed
7.
go back to reference Timofeeva M, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, et al. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. Int J Cancer. 2010;127:1547–61.CrossRefPubMed Timofeeva M, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, et al. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. Int J Cancer. 2010;127:1547–61.CrossRefPubMed
8.
go back to reference Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res. 2011;30:99.PubMedCentralCrossRefPubMed Zhan P, Wang Q, Qian Q, Wei SZ, Yu LK. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review. J Exp Clin Cancer Res. 2011;30:99.PubMedCentralCrossRefPubMed
9.
go back to reference Griffin CS, Simpson PJ, Wilson CR, Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol. 2000;2:757–61.CrossRefPubMed Griffin CS, Simpson PJ, Wilson CR, Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol. 2000;2:757–61.CrossRefPubMed
10.
go back to reference Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604–8.PubMed Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604–8.PubMed
11.
go back to reference Jin MJ, Chen K, Song L, Fan CH, Chen Q, Zhu YM, et al. The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population. Cancer Genet Cytogenet. 2005;163:38–43.CrossRefPubMed Jin MJ, Chen K, Song L, Fan CH, Chen Q, Zhu YM, et al. The association of the DNA repair gene XRCC3 Thr241Met polymorphism with susceptibility to colorectal cancer in a Chinese population. Cancer Genet Cytogenet. 2005;163:38–43.CrossRefPubMed
12.
go back to reference Gsur A, Bernhart K, Baierl A, Feik E, Fuhrlinger G, Hofer P, et al. No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. Cancer Epidemiol. 2011;35:e38–41.CrossRefPubMed Gsur A, Bernhart K, Baierl A, Feik E, Fuhrlinger G, Hofer P, et al. No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk. Cancer Epidemiol. 2011;35:e38–41.CrossRefPubMed
13.
go back to reference Huang M, Chen X, Qiu Y, Fan L, Chen J, Cai L. Relationship between XRCC3 gene polymorphisms and lung cancer. Wei Sheng Yan Jiu. 2011;40:187–90 [Article in Chinese].PubMed Huang M, Chen X, Qiu Y, Fan L, Chen J, Cai L. Relationship between XRCC3 gene polymorphisms and lung cancer. Wei Sheng Yan Jiu. 2011;40:187–90 [Article in Chinese].PubMed
14.
go back to reference Zhang ZL, Zhou CC, Zhang J, Tang L, Su B. Relationship between polymorphisms of DNA repair gene XRCC3 and susceptibility to lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 2007;30:936–40 [Article in Chinese].PubMed Zhang ZL, Zhou CC, Zhang J, Tang L, Su B. Relationship between polymorphisms of DNA repair gene XRCC3 and susceptibility to lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 2007;30:936–40 [Article in Chinese].PubMed
15.
17.
go back to reference Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMed
18.
19.
go back to reference Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 70-1.PubMedCentralCrossRefPubMed Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 70-1.PubMedCentralCrossRefPubMed
21.
go back to reference Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.CrossRefPubMed Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011;73:138–46.CrossRefPubMed
22.
go back to reference Xia WJ, Zhang YM, SU D, Shi F. Association of single nucleotide polymorphisms of DNA repair gene XRCC3-241 with non-small cell lung cancer. Zhejiang Med J. 2008;30:1291–3 [Article in Chinese]. Xia WJ, Zhang YM, SU D, Shi F. Association of single nucleotide polymorphisms of DNA repair gene XRCC3-241 with non-small cell lung cancer. Zhejiang Med J. 2008;30:1291–3 [Article in Chinese].
23.
go back to reference Liang G. Polymorphisms of DNA repair genes and carcinogen metabolizing enzymes genes and susceptibility to lung cancer. Chinese Peking Union Med Coll. 2004. [Article in Chinese] Liang G. Polymorphisms of DNA repair genes and carcinogen metabolizing enzymes genes and susceptibility to lung cancer. Chinese Peking Union Med Coll. 2004. [Article in Chinese]
24.
go back to reference Guo S, Li X, Gao M, Li Y, Song B, Niu W. The Relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in Northeastern Chinese. PLoS One. 2013;8:e56213.PubMedCentralCrossRefPubMed Guo S, Li X, Gao M, Li Y, Song B, Niu W. The Relationship between XRCC1 and XRCC3 gene polymorphisms and lung cancer risk in Northeastern Chinese. PLoS One. 2013;8:e56213.PubMedCentralCrossRefPubMed
25.
go back to reference Atinkaya C, Taspinar M, Sakiragaoglu O, Oz G, Yazici U, Oztuna D, et al. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case–control study. Hum Exp Toxicol. 2012;31:1074–80.CrossRefPubMed Atinkaya C, Taspinar M, Sakiragaoglu O, Oz G, Yazici U, Oztuna D, et al. The effect of CYP1A1, GSTT1 and GSTM1 polymorphisms on the risk of lung cancer: a case–control study. Hum Exp Toxicol. 2012;31:1074–80.CrossRefPubMed
26.
go back to reference Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case–control studies. Mol Biol Rep. 2012;39:9535–47.CrossRefPubMed Dai L, Duan F, Wang P, Song C, Wang K, Zhang J. XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case–control studies. Mol Biol Rep. 2012;39:9535–47.CrossRefPubMed
27.
go back to reference Liu L, Wu J, Wu C, Wang Y, Zhong R, Zhang X, et al. A functional polymorphism (−1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer. Cancer. 2011;117:5172–81.CrossRefPubMed Liu L, Wu J, Wu C, Wang Y, Zhong R, Zhang X, et al. A functional polymorphism (−1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer. Cancer. 2011;117:5172–81.CrossRefPubMed
28.
go back to reference Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513–30.PubMed Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513–30.PubMed
29.
go back to reference Stern MC, Umbach DM, Lunn RM, Taylor JA. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:939–43.PubMed Stern MC, Umbach DM, Lunn RM, Taylor JA. DNA repair gene XRCC3 codon 241 polymorphism, its interaction with smoking and XRCC1 polymorphisms, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:939–43.PubMed
30.
go back to reference Kawabata M, Kawabata T, Nishibori M. Role of recA/RAD51 family proteins in mammals. Acta Med Okayama. 2005;59:1–9.PubMed Kawabata M, Kawabata T, Nishibori M. Role of recA/RAD51 family proteins in mammals. Acta Med Okayama. 2005;59:1–9.PubMed
31.
go back to reference Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, et al. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case–control study in a Southern Italian population. Anticancer Res. 2008;28:2941–6.PubMed Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, et al. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case–control study in a Southern Italian population. Anticancer Res. 2008;28:2941–6.PubMed
32.
go back to reference Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593–600.PubMedCentralPubMed Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, et al. Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol. 2005;11:6593–600.PubMedCentralPubMed
33.
go back to reference Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, et al. XRCC3 5′-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2010;122:489–93.CrossRefPubMed Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, et al. XRCC3 5′-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2010;122:489–93.CrossRefPubMed
34.
go back to reference Sun H, Qiao Y, Zhang X, Xu L, Jia X, Sun D, et al. XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis. Cancer Sci. 2010;101:1777–82.CrossRefPubMed Sun H, Qiao Y, Zhang X, Xu L, Jia X, Sun D, et al. XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis. Cancer Sci. 2010;101:1777–82.CrossRefPubMed
35.
go back to reference Settheetham-Ishida W, Yuenyao P, Natphopsuk S, Settheetham D, Ishida T. Genetic risk of DNA repair gene polymorphisms (XRCC1 and XRCC3) for high risk human papillomavirus negative cervical cancer in Northeast Thailand. Asian Pac J Cancer Prev. 2011;12:963–6.PubMed Settheetham-Ishida W, Yuenyao P, Natphopsuk S, Settheetham D, Ishida T. Genetic risk of DNA repair gene polymorphisms (XRCC1 and XRCC3) for high risk human papillomavirus negative cervical cancer in Northeast Thailand. Asian Pac J Cancer Prev. 2011;12:963–6.PubMed
36.
go back to reference Peluso M, Munnia A, Piro S, Armillis A, Ceppi M, Matullo G, et al. Smoking, DNA adducts and number of risk DNA repair alleles in lung cancer cases, in subjects with benign lung diseases and in controls. J Nucleic Acids. 2010;2010:386798.PubMedCentralCrossRefPubMed Peluso M, Munnia A, Piro S, Armillis A, Ceppi M, Matullo G, et al. Smoking, DNA adducts and number of risk DNA repair alleles in lung cancer cases, in subjects with benign lung diseases and in controls. J Nucleic Acids. 2010;2010:386798.PubMedCentralCrossRefPubMed
37.
go back to reference Schroeder SA. New evidence that cigarette smoking remains the most important health hazard. N Engl J Med. 2013;368:389–90.CrossRefPubMed Schroeder SA. New evidence that cigarette smoking remains the most important health hazard. N Engl J Med. 2013;368:389–90.CrossRefPubMed
Metadata
Title
Association between the XRCC3 C241T polymorphism and lung cancer risk in the Asian population
Authors
Xin Tian
Ye Tian
Ping Ma
Chengguang Sui
Fandong Meng
Yan Li
Liye Fu
Tao Jiang
Yang Wang
Youhong Jiang
Publication date
01-10-2013
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2013
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-0806-z

Other articles of this Issue 5/2013

Tumor Biology 5/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine